JuLib | Articles & more

1

Hirnmetastasen – interdisziplinär zu einer personalisierten BehandlungBrain metastases–Interdisciplinary approach towards a personalized treatment

Grau, S.
2021

Der Chirurg, 92 (2021) 3, S. 200 - 209

“...Ruge, M....”
Published on 2021-01-27. Available in OpenAccess from 2022-01-27. Restricted

2

Abstract

Treatment monitoring of immunotherapy and targeted therapy using FET PET in patients with melanoma and lung cancer brain metastases: Initial experiences

Galldiks, Norbert
2019

“...Ruge, M. I....”

3

Abstract

Combined FET PET/MRI radiomics differentiates radiation injury from brain metastasis recurrence

Lohmann, Philipp
2019

“...Ruge, M. I....”

4

Journal Article

Monitoring treatment response to Erlotinib in EGFR-mutated nonesmall-cell lung cancer brain metastases using serial O-(2-[18F]fluoroethyl)-L-tyrosine PET

Abdulla, D. S. Y.
2019

Clinical lung cancer, 20 (2019) 2, S. e148-e151

“...Ruge, M....”
OpenAccess OpenAccess

5

Conference Presentation

Diagnosis of Pseudoprogression in Patients with Glioblastoma Using Amino Acid PET

Galldiks, N.
2015

2015

“...Ruge, M....”

6

Conference Presentation

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Ruge, M. I....”

7

Journal Article

Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases

Kickingereder, P.
2014

Journal of neuro-oncology, 120 (2014) 3, S. 615-623

“...Ruge, M. I....”

8

Contribution to a conference proceedings

LOW-DOSE RATE STEREOTACTIC IODINE-125 BRACHYTHERAPY FOR THE TREATMENT OF INOPERABLE PRIMARY AND RECURRENT GLIOBLASTOMA: SINGLE-CENTER EXPERIENCE WITH 201 CASES.

Kickingereder, P.
2014

2014

“...Ruge, M. I....”

9

Abstract

The use of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the diagnosis of patients with progressive and recurrent glioma.

Galldiks, N.
2014

2014

“...Ruge, M. I....”

10

Conference Presentation

Diagnosis of Pseudoprogression in Patients with Glioblastoma Using Amino Acid PET.

Galldiks, N.
2014

2014

“...Ruge, M. I....”

11

Conference Presentation

Differentiation of local recurrent brain metastasis from radiation-induced changes using O-(2-[18F]fluoroethyl)-L-tyrosine PET.

Galldiks, N.
2014

2014

“...Ruge, M. I....”

12

Journal Article

Role of O-(2-18F-Fluoroethyl)-l-Tyrosine PET as a Diagnostic Tool for Detection of Malignant Progression in Patients with Low-Grade Glioma

Galldiks, Norbert
2013

Journal of Nuclear Medicine Journal of nuclear medicine, 54 54 (2013 2013) 12 12, S. 2046-2054 2046-2054

“...Ruge, M...”

13

Poster

Role of [18F]fluoroethyl-L-tyrosine PET as diagnostic tool for malignant transformation in patients with low-grade glioma.

Galldiks, Norbert
2013

“...Ruge, M.I....”

14

Conference Presentation

Stellenwert der kinetischen O-(2-18F-Fluoroethyl)-L-Tyrosin PET bei Patienten mit sekundärer Malignisierung niedriggradiger Gliome.

Galldiks, Norbert
2013

“...Ruge, M.I....”

15

Journal Article

Stereotactic iodine-125 brachytherapy for the treatment of WHO grade II and III gliomas located in the central sulcus region

Ruge, M. I.
2013

Neuro-Oncology, 15 12, S. 1721 - 1731

“...Ruge, M. I....”
OpenAccess

16

Conference Presentation

Role of [18F]fluoroethyl-L-tyrosine PET as diagnostic tool for malignant transformation in patients with low-grade glioma.

Galldiks, Norbert
2013

“...Ruge, M. I....”

17

Conference Presentation

Stellenwert der kinetischen O-(2-18F-Fluoroethyl)-L-Tyrosin PET bei Patienten mit sekundärer Malignisierung niedriggradiger Gliome.

Galldiks, Norbert
2013

“...Ruge, M. I....”

18

Journal Article

Role of O-(2-18 F-Fluoroethyl)-L-Tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis

Galldiks, N.
2012

Journal of Nuclear Medicine Journal of nuclear medicine, 53 53 (2012 2012) 9 9, S. 1367-1374 1367-1374

“...Ruge, M.I....”

Narrow Search Results